Charles Schwab’s Xeris Biopharma Holdings XERS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $11.8M | Buy |
|
|||||
|
2025
Q2 | $2.65M | Buy |
|
|||||
|
2025
Q1 | $2.33M | Buy |
|
|||||
|
2024
Q4 | $1.37M | Sell |
|
|||||
|
2024
Q3 | $1.15M | Sell |
|
|||||
|
2024
Q2 | $910K | Buy |
|
|||||
|
2024
Q1 | $810K | Buy |
|
|||||
|
2023
Q4 | $856K | Sell |
|
|||||
|
2023
Q3 | $679K | Hold |
|
|||||
|
2023
Q2 | $956K | Sell |
|
|||||
|
2023
Q1 | $611K | Buy |
|
|||||
|
2022
Q4 | $463K | Buy |
|
|||||
|
2022
Q3 | $528K | Sell |
|
|||||
|
2022
Q2 | $522K | Buy |
|
|||||
|
2022
Q1 | $122K | Sell |
|
|||||
|
2021
Q4 | $197K | Buy |
|
|||||
|
2021
Q3 | $56K | Hold |
|
|||||
|
2021
Q2 | $92K | Sell |
|
|||||
|
2021
Q1 | $550K | Buy |
|
|||||
|
2020
Q4 | $580K | Buy |
|
|||||
|
2020
Q3 | $638K | Buy |
|
|||||
|
2020
Q2 | $247K | Buy |
|
|||||
|
2020
Q1 | $172K | Buy |
|
|||||
|
2019
Q4 | $477K | Hold |
|
|||||
|
2019
Q3 | $665K | Hold |
|
|||||
|
2019
Q2 | $774K | Buy |
|
|||||
|
2019
Q1 | $539K | Buy |
|
|||||
|
2018
Q4 | $247K | Hold |
|
|||||
|
2018
Q3 | $255K | Buy |
|